ES2987705T3 - Métodos y composiciones de los profármacos isoindolin-1,3-diona e isoindol útiles para el tratamiento del cáncer, colitis ulcerosa y enfermedades inflamatorias relacionadas - Google Patents

Métodos y composiciones de los profármacos isoindolin-1,3-diona e isoindol útiles para el tratamiento del cáncer, colitis ulcerosa y enfermedades inflamatorias relacionadas Download PDF

Info

Publication number
ES2987705T3
ES2987705T3 ES19712695T ES19712695T ES2987705T3 ES 2987705 T3 ES2987705 T3 ES 2987705T3 ES 19712695 T ES19712695 T ES 19712695T ES 19712695 T ES19712695 T ES 19712695T ES 2987705 T3 ES2987705 T3 ES 2987705T3
Authority
ES
Spain
Prior art keywords
acid
compound
group
radical
refers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES19712695T
Other languages
English (en)
Spanish (es)
Inventor
William R Baker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amgen Europe GmbH
Original Assignee
Amgen Europe GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Europe GmbH filed Critical Amgen Europe GmbH
Application granted granted Critical
Publication of ES2987705T3 publication Critical patent/ES2987705T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C245/00—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
    • C07C245/02—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides
    • C07C245/06—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
ES19712695T 2018-03-07 2019-03-06 Métodos y composiciones de los profármacos isoindolin-1,3-diona e isoindol útiles para el tratamiento del cáncer, colitis ulcerosa y enfermedades inflamatorias relacionadas Active ES2987705T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862639650P 2018-03-07 2018-03-07
PCT/EP2019/055576 WO2019170750A1 (en) 2018-03-07 2019-03-06 Methods and compositions of isoindoline-1,3-dione and isoindole prodrugs useful for treating cancer, ulcerative colitis and related inflammatory diseases

Publications (1)

Publication Number Publication Date
ES2987705T3 true ES2987705T3 (es) 2024-11-15

Family

ID=65894963

Family Applications (1)

Application Number Title Priority Date Filing Date
ES19712695T Active ES2987705T3 (es) 2018-03-07 2019-03-06 Métodos y composiciones de los profármacos isoindolin-1,3-diona e isoindol útiles para el tratamiento del cáncer, colitis ulcerosa y enfermedades inflamatorias relacionadas

Country Status (11)

Country Link
US (1) US11639332B2 (cg-RX-API-DMAC10.html)
EP (1) EP3762365B1 (cg-RX-API-DMAC10.html)
JP (1) JP7396991B2 (cg-RX-API-DMAC10.html)
AR (1) AR114666A1 (cg-RX-API-DMAC10.html)
AU (1) AU2019229583B2 (cg-RX-API-DMAC10.html)
CA (1) CA3093196A1 (cg-RX-API-DMAC10.html)
ES (1) ES2987705T3 (cg-RX-API-DMAC10.html)
MA (1) MA52266A (cg-RX-API-DMAC10.html)
MX (1) MX2020009288A (cg-RX-API-DMAC10.html)
TW (1) TW202000646A (cg-RX-API-DMAC10.html)
WO (1) WO2019170750A1 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN118370746A (zh) * 2024-04-25 2024-07-23 江苏省中医院 马尿酸在制备溃疡性结肠炎治疗药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2472965A (en) 1949-06-14 Metallized tetrakisazo dyes
US3951943A (en) 1974-03-18 1976-04-20 Chemetron Corporation Coupling process in the preparation of disazo diimides
EP0856562A1 (en) 1997-01-31 1998-08-05 Hodogaya Chemical Co Ltd Recording liquid and novel metal complex compound contained therein
US7182953B2 (en) 1999-12-15 2007-02-27 Celgene Corporation Methods and compositions for the prevention and treatment of atherosclerosis restenosis and related disorders
KR20030026936A (ko) * 2000-06-29 2003-04-03 니폰 가야꾸 가부시끼가이샤 색소증감 광전 변환소자
US7842662B2 (en) * 2006-11-10 2010-11-30 Cara Therapeutics, Inc. Synthetic peptide amide dimers
AU2008270363A1 (en) * 2007-06-29 2009-01-08 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin Targeting diazo prodrugs for the treatment of gastrointestinal diseases
DK2276483T3 (da) 2008-03-27 2014-06-10 Celgene Corp Faste former, omfattende (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindolin-1,3-dion, sammensætninger deraf og anvendelser deraf
WO2012083153A1 (en) * 2010-12-16 2012-06-21 Nektar Therapeutics Oligomer-containing apremilast moiety compounds
ES2673114T3 (es) 2011-01-10 2018-06-19 Celgene Corporation Derivados de fenetilsulfona isoindolina como inhibidores de PDE 4 y/o citoquinas

Also Published As

Publication number Publication date
JP7396991B2 (ja) 2023-12-12
JP2021517134A (ja) 2021-07-15
AR114666A1 (es) 2020-09-30
EP3762365B1 (en) 2024-02-21
AU2019229583B2 (en) 2024-06-13
US11639332B2 (en) 2023-05-02
AU2019229583A1 (en) 2020-09-10
MA52266A (fr) 2021-01-13
TW202000646A (zh) 2020-01-01
US20200392082A1 (en) 2020-12-17
CA3093196A1 (en) 2019-09-12
MX2020009288A (es) 2020-09-28
EP3762365A1 (en) 2021-01-13
WO2019170750A1 (en) 2019-09-12

Similar Documents

Publication Publication Date Title
ES2957383T3 (es) Compuestos de piridazinona y usos de estos
AU2018200635B2 (en) Cystathionine-y-gamma-lyase (CSE) inhibitors
ES2254470T3 (es) Compuestos inmunorreguladores, derivados de los mismos y su uso.
CN104662007B (zh) 胱硫醚‑γ‑裂合酶(CSE)抑制剂
CN101284799B (zh) 咖啡酰奎宁酸含氮衍生物及其制备方法和其药物组合物及用途
ES2717688T3 (es) Inhibidores de la PDE1 para uso en el tratamiento y/o prevención de lesiones de SNC, y enfermedades, trastornos o lesiones de SNP
ES2552764T3 (es) Métodos para el tratamiento de varias enfermedades y afecciones, y compuestos útiles para los mismos
ES2511942T3 (es) Análogos de cromenona como moduladores de sirtuina
JP7780201B2 (ja) 疼痛の予防および/または処置のためのnmnの使用および対応する組成物
AU2007243280A1 (en) Formulations containing pyridazine compounds for treating neuroinflammatory diseases
ES2774800T3 (es) Compuesto derivado de alfa-aminoamida y composición farmacéutica que contiene el mismo
JP5378221B2 (ja) 非常に高い皮膚浸透率を有するオキシカム及び関連化合物の正荷電水溶性プロドラッグ
ES2928666T3 (es) Piridinetionas, sus composiciones farmacéuticas y su uso terapéutico para el tratamiento de enfermedades proliferativas, inflamatorias, neurodegenerativas o inmunomediadas
BR112020014584A2 (pt) inibição do canal iônico do receptor de potencial transitório a1
ES2363056T3 (es) Utilización de 4-ciclopropilmetoxi-n-(3,5-dicloro-1-óxido-piridin-4-il)-5-(metoxi)piridin-2-carboxamida para el tratamiento de los traumatismos de la médula espinal.
EP3762365B1 (en) Methods and compositions of isoindoline-1,3-dione and isoindole prodrugs useful for treating cancer, ulcerative colitis and related inflammatory diseases
ES3040773T3 (en) Phospholipid-flavagline conjugates and methods of using the same for targeted cancer therapy
ES2233493T3 (es) Agentes terapeuticos y/o profilacticos para trastornos del sistema nervioso.
ES2978226T3 (es) Compuesto de carbamato y uso de la formulación que lo comprende para prevenir, aliviar o tratar el trastorno de estrés agudo o el trastorno de estrés postraumático
CN119925347B (zh) 化合物Pladienolide B作为抗蓖麻毒素保护剂的医药用途
WO2024002112A1 (zh) 一种治疗猫冠状或杯状病毒感染的方法
HK1200031A1 (en) Positively charged water-soluble prodrugs of oxicams and related compounds with very high skin penetration rate
HK1202115A1 (en) Positively charged water-soluble prodrugs of oxicams and related compounds with very high skin penetration rate
HK1200031B (en) Positively charged water-soluble prodrugs of oxicams and related compounds with very high skin penetration rate
HK1137427A (en) Positively charged water-soluble prodrugs of oxicams and related compounds with very high skin penetreation rate